Service de Microbiologie, Centre National de Référence Escherichia coli, Hôpital Robert-Debré, Paris, France.
Université de Paris, IAME, INSERM, Paris, France.
Antimicrob Agents Chemother. 2022 Feb 15;66(2):e0194921. doi: 10.1128/AAC.01949-21. Epub 2021 Dec 6.
We described and characterized Shiga-toxin-producing Escherichia coli (STEC) strains with high levels of resistance to azithromycin isolated in France between 2004 and 2020. Nine of 1,715 (0.52%) STEC strains were resistant to azithromycin, with an increase since 2017. One isolate carried a plasmid-borne (C)-(G) gene combination, described here for the first time for E. coli. Azithromycin resistance, although rare, needs consideration, as this treatment may be useful in cases of STEC infection.
我们描述并鉴定了 2004 年至 2020 年间在法国分离出的具有高水平耐阿奇霉素的产志贺毒素大肠杆菌(STEC)菌株。在 1715 株 STEC 菌株中,有 9 株(0.52%)对阿奇霉素耐药,自 2017 年以来有所增加。一个分离株携带质粒携带的(C)-(G)基因组合,这是首次在大肠杆菌中描述。阿奇霉素耐药虽然罕见,但仍需考虑,因为这种治疗可能对 STEC 感染有用。